Management of AIDS-associated Kaposi's sarcoma: A multidisciplinary perspective

ONCOLOGY

Volumn 12, Issue 2 SUPPL. 3, 1998, Pages 9-24

  Von Roenn, J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CHORIONIC GONADOTROPIN; LIQUID NITROGEN; PACLITAXEL; RECOMBINANT ALPHA INTERFERON; RITONAVIR; TETRADECYL SULFATE SODIUM; VINBLASTINE;

AIDS RELATED COMPLEX; ANTIVIRAL ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CELL PROLIFERATION; CONFERENCE PAPER; CRYOTHERAPY; DISEASE ASSOCIATION; DISEASE CONTROL; HELPER CELL; HUMAN; KAPOSI SARCOMA; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT PLANNING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; SARCOMA, KAPOSI;

EID: 0031991376     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Centers for Disease Control: Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. Morbid Mortal Weekly Rep 30:305-308, 1981.
2. Tappero JW, Berger TG, Kaplan LD, et al: Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): A phase II trial. J Acquir Immune Defic Syndr 4:839-846, 1991.
3. Boudreaux AA, Smith LL, Cosby CD, et al Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome: A clinical trial to evaluate efficacy and discomfort associated with injection. J Am Acad Dermatol 28:61-65, 1993.
4. Gill PS, Lunardi-Iskandar Y, Louie S, et al: The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med 335:1261-1269, 1996.
5. Stelzer KJ, Griffin TW. A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 27:1057-1061, 1993
6. Stelzer KJ, Griffin TW, Koh WJ: Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 71:1322-1325, 1993
7. Ho DD, Hartshorn KL, Rota TR, et al: Recombinant human Interferon alpha-.A suppresses HTLV-III replication in vitro. Lancet 1:602-604, 1985.
8. Tilg H, Mier JM, Vogel W, et al: Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol 150:4687-4692, 1993.
9. Tilg H, Vogel W, Dinarello CA. Interferon-α induces circulating tumor necrosis factor receptor in humans. Blood 85:433-435, 1995.
10. Fidler IJ, Singh RK, Gutman M, et al: Interferons alpha and beta down regulate the expression of basic fibroblast growth factor (bFGF) in human carcinomas (abstract). Proc Am Assoc Cancer Res 35:47, 1994.
11. Krown SE, Gold JWM, Niedzwiecki D, et al: Interferon- with zidovudine: Safety, tolerance, and clinical and virologie effects in patients with Kaposi's sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:812-821, 1990.
12. Fischl MA, Uttamchandani R, Resnick L, et al: A phase I study of recombinant human interferon alfa-n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr 4:1-10, 1991.
13. Kovacs JA, Deyton L, Davey R, et al: Combined zidovudine and interferon-α therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 111:280-287, 1989.
14. Real FX, Krown SE, Oettgen HF: Kaposi's sarcoma and the acquired immunodeficiency syndrome: Treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 4:544-551, 1986.
15. Evans LM, Itri LM, Campion M, et al: Inteiferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother 10:39-50, 1991.
16. Fischl MA, Finkelstein DM, He W, et al: A phase II study of recombinant human interferon-α2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovir 11:379-384, 1996.
17. Krown SE, Paredes J, Bundow D, et al: Interferon-α, zidovudine and granulocyte-macrophage colony-stimulating factor: A phase I trial in patients with Kaposi's sarcoma associated with the acquired immunodeficiency syndrome (AIDS). J Clin Oncol 10:1344-1351, 1992.
18. Scadden DT, Bering HA, Levine JD, et al: Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J Clin Oncol 9:802-808, 1991
19. Krown SE, Testa MA, Huang J: AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. J Clin Oncol 15:3085-3092, 1997.
20. Simpson JK, Miller RF, Spittle MF: Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma. Clin Oncol 5:372-374, 1993.
21. Harrison M, Tomlinson D, Stewart S: Liposomal-entrapped doxorubicin: An active agent in ALDS-related Kaposi's sarcoma. J Clin Oncol 13:914-920, 1995.
22. Goebel FD, Goldstein D, Goos M, et al: Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. Br J Cancer 73:989-994, 1996.
23. Mitsuyasu R, Von Roenn J, Krown S, et al: Comparison study of liposomal doxorubicin (Dox) alone or with bleomycin and vincristine (DBV) for treatment of advanced AIDS-associated Kaposi's sarcoma (AIDS-KS): AIDS Clinical Trials Group (ACTG) protocol 286 (abstract). Proc Am Soc Clin Oncol 16:55a, 1997.
24. Stewart JSW, Jablonowski H, Goebel FD, et al: A randomized comparison trial of Doxil versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma (abstract). Proc Am Soc Clin Oncol 16:55a, 1997.
25. Northfelt DW, Dezube BJ, Thommes JA, et al: Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. J Clin Oncol 15:653-659, 1997.
26. Northfelt DW, Dezube B, Miller B, et al: Randomized comparative trial of Doxil vs. adriamycin, bieomycin, and vincristine (ABV) in the treatment of severe AIDS-related Kaposi's sarcoma (abstract). Blood 86:382a, 1995.
27. Money-Kyrle JF, Bates F, Ready J, et al: Liposomal daunorubicin in advanced Kaposi's sarcoma: A phase II study. Clin Oncol (R Coll Radiol) 5:367-371, 1993
28. Presant CA, Scolaro M, Kennedy P, et al: Liposomal daunorubicin treatment of HTV-associated Kaposi's sarcoma. Lancet 341:1242-1243, 1993.
29. Gill PS, Wernz J, Scadden DT, et al: Randomized phase II trial of liposomal daunorubicin (DaunoXome) versus doxorubicin, bleomycin, vincristine (ABV) in AIDS-related Kaposi's sarcoma. J Clin Oncol 14:2353-2364, 1996.
30. Gill PS, Wernz J, Myers A, et al: Liposomal encapsulated daunorubicin (DaunoXome) in AIDS-related pulmonary Kaposi's sarcoma (abstract). Proc Am Soc Clin Oncol 16:55a, 1997.
31. Saville MW, Lietzau J, Pluda JM, et al: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346:26-28, 1995.
32. Gill PS, Tulpule A, Reynolds T, et al: Paclitaxel (Taxol) in the treatment of relapsed or refractory advanced AIDS-related Kaposi's sarcoma (abstract). Proc Am Soc Clin Oncol 15:306, 1996.
33. Chak LY, Gill PS, Levine AM, et al: Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol 6:863-867, 1988.
34. Lucatoro FM, Sapp JP: Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients: A preliminary study. Oral Surg Oral Med Oral Pathol 75:192-198, 1993.
35. Flaitz CM, Nichols CM, Hicks MJ: Role of intralesional vinblastine administration in treat ment of oral Kaposi's sarcoma in AIDS. Eur J Cancer 31B(4):280-285, 1995.
36. Northfelt DW: Treatment of Kaposi's sarcoma. Drugs 48:569-582, 1994.
37. Cooper JS, Fried PR: Defining the role of radiation therapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 13:35-39, 1987.
38. Lee VW, Fuller JD, O'Brien MI, et al: Pulmonary Kaposi's sarcoma in patients with AIDS. Scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 180:409, 1991.
39. Meyer JL: Whole lung irradiation for Kaposi's sarcoma. Am J Clin Oncol. 16(5):372-376, 1993.
40. Gompels MM, Hill A, Jenkins P, et al: Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS 6:1175-1180, 1992.
41. Gill PS, Rarick MU, Bernstein-Singer M, et al: Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 13:315-319, 1990.
42. Rizzardini G, Pastecchia C, Vigevani GM, et al: Stealth liposomal doxorubicin or bleomycin/vincristine for the treatment of AIDS-related Kaposi's sarcoma J Acquired Immune Defic Syndr Hum Retrovirol 14(4): A20, 1997. (Abstracts of the National AIDS Malignancy Conference, Bethesda, MD, April 28-30, 1997, abstract 17).
43. Gill PS, Rarick M, McCutchon JA, et al: Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial. Am J Med 90:427-433, 1991.
44. Mitsuyasu RT, Gill P, Paredes J, et al: Combination chemotherapy, Adriamycin, bleomycin, vincristine (ABV) with dideoxyinosine (ddI) or dideoxycytidine (ddC) in advanced AIDS-related Kaposi's sarcoma. (ACTG 163) (abstract 822). Proc Am Soc Clin Oncol 14:289, 1995.
45. Fischl MA, Krown SE, O'Boyle KP, et al: Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. J AIDS 6:259-264, 1993.
46. Gruenaug M, Bogner JR, Loch O, et al: Liposomal doxorubicin in pulmonary Kaposi's sarcoma: improved survival as compared to patients without liposomal doxorubicin (abstract TU:B.2221). XI International Conference on AIDS, 1996.
47. Berry G, Billingham M, Alderman E, et al: Reduced cardiotoxicity of Doxil (pegylated liposomal doxorubicin) in AIDS Kaposi's sarcoma patients compared to a matched control group of cancer patients given doxorubicin (abstract 843). Proc Am Soc Clin Oncol 35:303, 1996.
48. Volm MD, Wernz J: Patients with advanced AIDS-related Kaposi's sarcoma (EKS) no longer require systemic therapy after introduction of effective antiviral therapy (abstract). Proc Am Soc Clin Oncol 16:46a, 1997.